Désogestrel ( DrugBank: Désogestrel )


1 disease
IDDisease name (Link within this page)Number of trials
230Alveolar hypoventilation syndrome1

230. Alveolar hypoventilation syndrome


Clinical trials : 8 Drugs : 11 - (DrugBank : 5) / Drug target genes : 18 - Drug target pathways : 28
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-000989-35-FR
(EUCTR)
06/05/2011N/AN/A - RESPIRONDINE
MedDRA version: 14.0;Level: PT;Classification code 10066131;Term: Congenital central hypoventilation syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders
Trade Name: Cerazette
Product Name: Cerazette
INN or Proposed INN: Désogestrel
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNAFemale: yes
Male: no
Phase 2France